CATX
AMEX Perspective Therapeutics, Inc.$2.75 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.75
- YTD change
- +0.00%
- vs 20-day SMA
- -2.81%
- vs 200-day SMA
- -23.77%
Price ranges
Price & Performance
-1.67 (-37.78%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 85.6% away from all-time highs of $19.05
- CATX is up 0% since the beginning of the year
- CATX is down 20% over the past 12 months
- CATX is down 11% over the past 1 month
- 24% of all CATX investors are betting against CATX
- Number of investors short CATX has gone down 5% versus last month
CATX reads neutral: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -19.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +4.96%
- vs 8-day SMA
- +2.61%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.